Drug details
Emgality (galcanezumab-gnlm injection)
type of CGRP Monoclonal Antibodies
Emgality (galcanezumab-gnlm) is a calcitonin-gene related peptide antagonist indicated for the preventive treatment of migraine in adults.
The drug is often used to treat Migraine .
This drug may have the following side effects:
- injection site reactions such as pain, redness, and itching
The following drugs are related to Emgality, either as a replacement or used together:
- Aimovig (erenumab-aooe injection, for subcutaneous use)
- Axert (almotriptan malate)
- Amerge (naratriptan)
- Botox (botulinum toxin type a)
- Fioricet with Codeine (butalbital acetaminophen caffeine capsules)
- Fioricet (butalbital and acetaminophen tablets)
- Fiorinal with Codeine (butalbital compound with codeine)
- Cataflam (diclofenac potassium immediate-release tablets)
- Trudhesa (dihydroergotamine mesylate nasal spray)
- Relpax (eletriptan hydrobromide)
- Frova (frovatriptan succinate)
- Imitrex (sumatriptan succinate)
- Imitrex Injection (sumatriptan succinate injection)
- Imitrex Nasal Spray (sumatriptan nasal spray)
- Inderal (propranolol)
- Inderal LA (propranolol)
- Inderal XL (inderal xl propranolol hydrochloride capsules)
- Reyvow (lasmiditan tablets)
- Maxalt (rizatriptan benzoate)
- Nurtec ODT (rimegepant orally disintegrating tablets, for sublingual or oral use)
- RizaFilm (rizatriptan oral film)
- Stavzor (valproic acid)
- Treximet (sumatriptan and naproxen sodium tablets)
- Zembrace-SymTouch (sumatriptan succinate subcutaneous injection, usp)
- Zavzpret (zavegepant nasal spray)
- Zomig (zolmitriptan)
- Zomig Nasal Spray (zolmitriptan nasal spray)